Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
STAT+
Biotech
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Biotech stocks are soaring. Here are four reasons why

  • Adam Feuerstein

By Adam Feuerstein June 20, 2017

Reprints
Biotech column IMAGE
Alex Hogan/STAT

Biotech stocks are soaring this week. Two widely owned exchange-traded funds, iShares Nasdaq Biotechnology and the SPDR S&P Biotech ETF , are up 6 percent and 5 percent respectively, over the past two trading days.

What’s changed? Here are a few guesses:

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Adam Feuerstein

Adam Feuerstein

Senior Writer, Biotech

Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast.

Tags

Top FDA official: Agency needs to start using accelerated…
Top FDA official: Agency needs to start using accelerated approval for gene therapies
Human reproductive cloning: The curious incident of the dog…
Human reproductive cloning: The curious incident of the dog in the night-time
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Senator calls for probe of conflict of interest on…
Senator calls for probe of conflict of interest on federal panel overseeing dietary guidelines
Top FDA official: Agency needs to start using accelerated…
Top FDA official: Agency needs to start using accelerated approval for gene therapies
Pharmalittle: Manufacturers say bird flu shots for humans can…
Pharmalittle: Manufacturers say bird flu shots for humans can be made quickly; obesity guidelines for children…

Comments are closed.

Recommended Stories